RxDoctor Payments DataLook up a doctor →

Tanya Geist

Surgical · Amherst, NYNPI 1174666945

Payments from drug & device makers

$43,318in general payments, 2019–2025

Across 1,003 payments — averaging $43.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Argenx US, Inc.$7K
  • Amgen$6K
  • UCB, Inc.$5K
  • Amylyx Pharmaceuticals, Inc.$4K
  • AstraZeneca$4K
  • Genentech USA, Inc.$2K
  • plus $15K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Argenx US, Inc.24$6,987
Amgen(2 entities)78$6,214
UCB, Inc.68$4,859
Amylyx Pharmaceuticals, Inc.19$4,319
AstraZeneca(2 entities)63$4,154
Genentech USA, Inc.84$1,951
Johnson & Johnson(2 entities)17$1,732
AbbVie(2 entities)79$1,391
MDD US Operations, LLC38$1,258
Novartis79$1,065
Biogen41$755
Alnylam Pharmaceuticals Inc.20$736
Teva Pharmaceuticals USA, Inc.34$670
Tanabe Pharma America, Inc.29$535
EMD Serono, Inc.7$453
Nevro Corp.8$318
Pfizer15$273
SK Life Science, Inc.11$272
Avanir Pharmaceuticals, Inc.11$266
Neurocrine Biosciences, Inc.15$262
Catalyst Pharmaceuticals, Inc.11$257
Lundbeck LLC15$245
Jazz Pharmaceuticals Inc.11$230
CSL Behring10$218
Sanofi6$217
Lilly USA, LLC12$216
GE HealthCare21$198
Merz Pharmaceuticals, LLC8$174
Biohaven Pharmaceutical Holding Company Ltd.11$168
Livanova USA, Inc.8$162
Genentech, Inc.8$158
TG Therapeutics, Inc.8$155
Bristol Myers Squibb10$151
Grifols USA, LLC6$150
Adamas Pharmaceuticals, Inc.6$139
Octapharma USA, Inc.7$131
Kyowa Kirin, Inc.6$125
Supernus Pharmaceuticals, Inc.7$120
Abbott6$113
Acadia Pharmaceuticals Inc8$111
Takeda Pharmaceuticals U.S.A., Inc.5$111
Mallinckrodt Hospital Products Inc.6$101
Arbor Pharmaceuticals, Inc.5$90
Eisai Inc.4$89
Upsher-smith Laboratories LLC4$64
Acorda Therapeutics, Inc3$63
Otsuka America Pharmaceutical, Inc.3$62
Biohaven Pharmaceuticals, Inc.4$62
Vanda Pharmaceuticals Inc.3$61
Axsome Therapeutics, Inc.4$60
Averitas Pharma Inc.3$60
Avion Pharmaceuticals4$58
Harmony Biosciences LLC3$58
Azurity Pharmaceuticals, Inc.3$53
Amneal Pharmaceuticals LLC4$52
Banner Life Sciences, LLC3$42
Xeris Pharmaceuticals, Inc.2$41
Boston Scientific1$38
ANI Pharmaceuticals, Inc.2$34
Neurelis, Inc.2$32

How this compares

$43,318 in reported general payments places this provider in the 95th percentile of 1,544 surgical providers in New York.

See all surgical providers in New York →

Medicare billing

Part B allowed, 2024
$46,476
Medicare patients
187
Services billed
588

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other surgical in Amherst

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →